title: Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma.
abstract: Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide, accounting for an estimated 600,000 deaths annually. Aberrant methylation, consisting of DNA hypomethylation and/or promoter gene CpG hypermethylation, is implicated in the development of a variety of solid tumors, including HCC. We analyzed the global levels of DNA methylation as well as the methylation status of 105 putative tumor suppressor genes and found that the extent of genome-wide hypomethylation and CpG hypermethylation correlates with biological features and clinical outcome of HCC patients. We identified activation of Ras and downstream Ras effectors (ERK, AKT, and RAL) due to epigenetic silencing of inhibitors of the Ras pathway in all HCC. Further, selective inactivation of SPRY1 and -2, DAB2, and SOCS4 and -5 genes and inhibitors of angiogenesis (BNIP3, BNIP3L, IGFBP3, and EGLN2) was associated with poor prognosis. Importantly, several epigenetically silenced putative tumor suppressor genes found in HCC were also inactivated in the nontumorous liver. Our results assign both therapeutic and chemopreventive significance to methylation patterns in human HCC and open the possibility of using molecular targets, including those identified in this study, to effectively inhibit HCC development and progression.
authors: Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland 20892-4262, USA.
authors: Diego F
authors: DF
authors: Calvisi
authors: Sara
authors: S
authors: Ladu
authors: Alexis
authors: A
authors: Gorden
authors: Miriam
authors: M
authors: Farina
authors: Ju-Seog
authors: JS
authors: Lee
authors: Elizabeth A
authors: EA
authors: Conner
authors: Insa
authors: I
authors: Schroeder
authors: Valentina M
authors: VM
authors: Factor
authors: Snorri S
authors: SS
authors: Thorgeirsson
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000098:blood supply / Q000235:genetics* / Q000378:metabolism / Q000473:pathology*; D019175:DNA Methylation; D018450:Disease Progression; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005260:Female; D015894:Genome, Human / Q000235:genetics; D006801:Humans; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D011485:Protein Binding; D015398:Signal Transduction / Q000187:drug effects; D018631:ras Proteins / Q000037:antagonists & inhibitors / Q000378:metabolism
chemical_list: D004791:Enzyme Inhibitors; D018631:ras Proteins
references: Biochem Biophys Res Commun. 1999 Sep 7;262(3):624-8
references: 10471374
references: Trends Cell Biol. 2004 Nov;14(11):639-47
references: 15519853
references: Oncogene. 2004 Nov 11;23(53):8695-9
references: 15378027
references: Cancer Cell. 2004 Nov;6(5):447-58
references: 15542429
references: Nat Genet. 2004 Dec;36(12):1306-11
references: 15565109
references: Oncogene. 2004 Dec 16;23(58):9427-31
references: 15543236
references: Cancer Res. 2004 Dec 15;64(24):8919-23
references: 15604253
references: Curr Opin Oncol. 2005 Jan;17(1):55-60
references: 15608514
references: Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2328-33
references: 15695332
references: J Biol Chem. 2005 Feb 25;280(8):7038-48
references: 15590694
references: Oncogene. 2005 Mar 24;24(13):2166-74
references: 15735753
references: Cancer Res. 2005 Apr 15;65(8):3117-25
references: 15833841
references: Biochim Biophys Acta. 2004 Mar 4;1654(1):23-37
references: 14984765
references: Carcinogenesis. 2004 Apr;25(4):527-33
references: 14688025
references: Cancer Cell. 2004 Mar;5(3):215-9
references: 15050913
references: Nat Genet. 2004 Apr;36(4):417-22
references: 15034581
references: Science. 2004 Apr 23;304(5670):554
references: 15016963
references: Gastroenterology. 2004 May;126(5):1374-86
references: 15131798
references: Nat Rev Mol Cell Biol. 2004 Jun;5(6):441-50
references: 15173823
references: Cancer Res. 2004 Jul 1;64(13):4472-80
references: 15231656
references: Nature. 2004 Aug 12;430(7001):797-802
references: 15306814
references: Hepatology. 2004 Sep;40(3):667-76
references: 15349906
references: Cancer Res. 2004 Sep 15;64(18):6410-5
references: 15374948
references: Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):5998-6005
references: 15447983
references: Oncogene. 2004 Oct 7;23(46):7726-33
references: 15361843
references: Semin Cancer Biol. 2004 Dec;14(6):427-32
references: 15489135
references: Nucleic Acids Res. 2004;32(19):5742-9
references: 15509869
references: Oncogene. 1989 Jul;4(7):923-8
references: 2666911
references: Nucleic Acids Res. 1991 Aug 11;19(15):4293
references: 1870982
references: Nucleic Acids Res. 1997 Jun 15;25(12):2532-4
references: 9171110
references: Int J Cancer. 1999 Oct 29;83(3):309-13
references: 10495421
references: Nat Rev Cancer. 2005 Dec;5(12):921-9
references: 16341083
references: Int J Cancer. 2003 Aug 10;106(1):52-9
references: 12794756
references: Am J Pathol. 2003 Sep;163(3):1101-7
references: 12937151
references: Nat Rev Cancer. 2003 Oct;3(10):721-32
references: 13130303
references: Am J Pathol. 2003 Oct;163(4):1371-8
references: 14507645
references: N Engl J Med. 2003 Nov 20;349(21):2042-54
references: 14627790
references: Cell Res. 2003 Oct;13(5):319-33
references: 14672555
references: Cancer Res. 1998 Jan 1;58(1):123-34
references: 9426068
references: Nat Rev Genet. 2006 Jan;7(1):21-33
references: 16369569
references: Gastroenterology. 2006 Feb;130(2):548-65
references: 16472607
references: Mol Cancer Ther. 2006 Feb;5(2):467-75
references: 16505122
references: Gastroenterology. 2006 Apr;130(4):1117-28
references: 16618406
references: Nature. 2006 Apr 27;440(7088):1222-6
references: 16642001
references: Nat Genet. 2006 Jul;38(7):787-93
references: 16804544
references: Cold Spring Harb Symp Quant Biol. 2005;70:329-33
references: 16869769
references: Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14080-5
references: 16963560
references: Oncogene. 2006 Oct 5;25(45):6056-66
references: 16652141
references: Mutat Res. 2006 Nov-Dec;613(2-3):76-102
references: 16979375
references: Biochim Biophys Acta. 2007 Jan;1775(1):138-62
references: 17045745
references: Cancer Res. 2006 Dec 15;66(24):11851-8
references: 17178882
references: Cell. 2007 Feb 23;128(4):683-92
references: 17320506
references: Nat Genet. 2007 Mar;39(3):289-90
references: 17325677
references: Cancer Res. 2007 Mar 1;67(5):1927-34
references: 17332319
references: Nat Genet. 2000 Jul;25(3):315-9
references: 10888881
references: Int J Oncol. 2000 Sep;17(3):507-12
references: 10938391
references: J Biol Chem. 2000 Oct 13;275(41):31805-12
references: 10924517
references: Hepatology. 2001 Mar;33(3):561-8
references: 11230735
references: Cancer Res. 2001 Mar 1;61(5):2085-91
references: 11280770
references: J Biol Chem. 2001 Jul 20;276(29):26814-8
references: 11359772
references: Oncogene. 2001 Oct 18;20(47):6960-4
references: 11687976
references: Cancer Res. 2001 Nov 15;61(22):8094-9
references: 11719434
references: Nature. 2002 Apr 4;416(6880):552-6
references: 11932749
references: Hepatology. 2002 May;35(5):1134-43
references: 11981763
references: Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):10060-5
references: 12110732
references: Nat Genet. 2002 Aug;31(4):339-46
references: 12149612
references: Cancer Res. 2002 Aug 1;62(15):4478-83
references: 12154058
references: Semin Cancer Biol. 2002 Oct;12(5):331-7
references: 12191632
references: Hepatology. 2002 Sep;36(3):692-701
references: 12198663
references: BMC Cancer. 2002 Nov 15;2:29
references: 12433278
references: J Biol Chem. 2003 Feb 28;278(9):6936-41
references: 12473651
references: Science. 2003 Apr 18;300(5618):489-92
references: 12702876
references: Nature. 1998 Sep 3;395(6697):89-93
references: 9738504
references: Cancer. 1999 Jan 1;85(1):112-8
references: 9921982
references: Nucleic Acids Res. 1999 Jun 1;27(11):2291-8
references: 10325416
references: Proc Natl Acad Sci U S A. 1999 Jul 20;96(15):8681-6
references: 10411935